
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Discovery
Sponsor : Andreessen Horowitz
Deal Size : $43.0 million
Deal Type : Series A Financing
Arda Therapeutics Secures $43M Series A for Targeted Cell Depletion Therapies
Details : The proceeds will be used to advance targeted cell depletion therapies for the treatment of chronic diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 09, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Discovery
Sponsor : Andreessen Horowitz
Deal Size : $43.0 million
Deal Type : Series A Financing
